1 year return (CAGR)
-99.72%
Carisma Therapeutics Inc. Exchange (NASDAQ, USD)
CARM
0.00
-0.00 (-12.50%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-94.81%
5 year return (CAGR)
-86.95%
10 year return (CAGR)
-69.07%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
29.29K
Price/Sales
0.00
Ent value
4.67M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
0.00
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.00 |
| Daily high | 0.00 |
| Daily low | 0.00 |
| Daily Volume | 1K |
| All-time high | 347.40 |
| 1y analyst estimate | 1.00 |
| Beta | -28.87 |
| EPS (TTM) | 0.19 |
| Dividend per share | 0.00 |
| Ex-div date | 8 Mar 2023 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CARM | S&P500 | |
| Current price drop from All-time high | -100.00% | -2.08% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 5 Jun 2026 | 9 Mar 2009 |
| Avg drop from high | -87.23% | -10.68% |
| Avg time to new high | 244 days | 12 days |
| Max time to new high | 3161 days | 1805 days |
News
